LSC Webinars CELL All

31. Clinical-Grade Manufacturing Of Difficult-To-Transduce Cells 3/20/2025

    Discover how Miltenyi R&D and Bioindustry experts revolutionize cellular therapy with BaEV-env LVVs as well as gain insights into preclinical evaluations and clinical-grade product development for CAR-NK cells.

32. Tools For Efficient Downstream Processing Of Antibody-Based Therapeutics 3/20/2025

    Watch and discover how to effectively utilize chromatography tools for improved purification of therapeutic monoclonal antibodies and antibody derivatives.

33. Who's In Charge? How To Ensure Effective Trial Oversight, Leadership 3/19/2025

    Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

34. Human Factors Testing: Engaging End-Users In Med Device Development 3/11/2025

    Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

35. Discovery Through Commercialization: A Biologic Drug's Analytical Journey 3/4/2025

    Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

36. Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective 2/18/2025

    Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.

37. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.

38. Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics 1/22/2025

    Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

39. Quantifying And Assessing Cleaning And Disinfection Residues: A Case Study 1/16/2025

    Ensure your ATMP facility meets the latest Annex 1 standards for cleaning & disinfection residue control with the help of practical guidance and a case study detailed in this presentation.

40. Rapid Process Development And Technical Support For AAV Scaleup 12/17/2024

    Accelerate your AAV production journey. Learn how rapid process development and expert support can streamline your path from vial to purified bulk, ensuring scalable and efficient manufacturing.